Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Translational Immunology is Scopus-indexed (Q1, CiteScore 7.2), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 2050-0068Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nursing (all) | 5 / 144 | 96th | Q1 |
| Immunology and Allergy | 63 / 234 | 73rd | Q2 |
| Immunology | 70 / 243 | 71st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 7.2.
Clinical and Translational Immunology is Q1 in Nursing (all) (rank 5 of 144), Q2 in Immunology and Allergy (rank 63 of 234) and Q2 in Immunology (rank 70 of 243), by CiteScore 2025.
Clinical and Translational Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.2, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.312, quartile Q1, with an H-index of 64.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$3,070 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Translational Immunology is published by John Wiley & Sons Inc. Its ISSN is 2050-0068.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Clinical and Translational Immunology has an h-index of 76 and a 2-year mean of 2.9 citations per paper (OpenAlex). Its Scopus CiteScore is 7.2, quartile Q1. On 2-year citations it ranks #19 of 141 Scopus journals in Nursing (all).
Clinical and Translational Immunology published 59 papers in 2025; its busiest recent year was 2020 with 144. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Australia (30.2%), China (14.3%) and United States (10.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.